• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Article

NEW SALES DIVISION

Galderma Laboratories has formed a new sales division, Theracutix, which will supplement the company's two current sales divisions: Galderma and CutiScience.

Related Videos
Related Content
Answering Your Questions About Cosmeceutical Peptides
September 20th 2024

Answering Your Questions About Cosmeceutical Peptides

The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
August 1st 2023

The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis

SPROUT Trial Highlights Benefits of Apremilast for Pediatric Psoriasis
September 12th 2024

SPROUT Trial Highlights Benefits of Apremilast for Pediatric Psoriasis

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
March 26th 2022

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

Availability of Apremilast in US for Pediatric Patients Opens Avenues for Expanded Treatment Options and Oral Therapy
September 9th 2024

Availability of Apremilast in US for Pediatric Patients Opens Avenues for Expanded Treatment Options and Oral Therapy

LC-OCT Demonstrates Non-Invasive Evaluation Capabilities of Dermal Fillers
August 29th 2024

LC-OCT Demonstrates Non-Invasive Evaluation Capabilities of Dermal Fillers

© 2024 MJH Life Sciences

All rights reserved.